School-Based Medication Evaluations: Implications for School Personnel and Physicians

  • Robert J. VolpeEmail author
  • Brian Daniels
  • Christina Sakai
Part of the Pediatric School Psychology book series (PSP)


This chapter presents an overview of assessment and medication-monitoring procedures that can be completed in the school setting to collect information on symptom severity/improvement, adverse events, and educational outcomes associated with psychopharmacological treatment. Commonly encountered systemic barriers to these procedures and solutions to these challenges are presented. A set of references and web-based materials are provided to readers for additional information.


Medication evaluation Side effects Progress monitoring Medication titration Medication effectiveness School-based evaluation ACMME Consultation 



The authors would like to thank Wanda Visnick for sharing her expertise in the delivery of school-based mental health services.


  1. American Academy of Pediatrics, Committee on Quality Improvement, & Subcommittee on Attention-Deficit/Hyperactivity Disorder. (2011). ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 128, 1–16.Google Scholar
  2. Baweja, R., Belin, P. J., Humphrey, H. H., Babocsai, L., Pariseau, M. E., Waschbusch, D. A., … Waxmonsky, J. G. (2016). The effectiveness and tolerability of central nervous system stimulants in school-age children with attention-deficit/hyperactivity disorder and disruptive mood dysregulation disorder across home and school. Journal of Child and Adolescent Psychopharmacology, 26, 154–163.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics, 86, 184–192.PubMedGoogle Scholar
  4. Barkley, R. A., & Murphy, K. R. (2006). Attention-deficit hyperactivity disorder: A clinical workbook. New York: Guilford Press.Google Scholar
  5. Briesch, A. M., Chafouleas, S. M., & Riley-Tillman, T. C. (2016). Direct behavior rating (DBR): Linking assessment, communication, and intervention. New York, NY: Guilford Press.Google Scholar
  6. Briesch, A. M., Volpe, R. J., & Floyd, R. G. (in press). A practical guide to classroom observation. New York: Guilford Press.Google Scholar
  7. Carlson, J. S., & Demaray, M. K. (2001, February). A survey of knowledge and training in school psychopharamacology. Poster presented at the annual National Association of School Psychologists Convention, Washington, DC.Google Scholar
  8. Chirdkiatgumchai, V., Xiao, H., Fredstrom, B. K., Adams, R. E., Epstein, J. N., Shah, S. S., … Froehlich, T. E. (2013). National trends in psychotropic medication use in young children: 1994–2009. Pediatrics, 132, 615–623.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Connor, D. F. (2015). Stimulant and nonstimulant medications for children with ADHD. In R. A. Barkley (Ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (pp. 666–685). New York: Guildford Press.Google Scholar
  10. DuPaul, G. J., Anastopoulos, A. D., Kwasnik, D., Barkley, R. A., & McMurray, M. B. (1996). Methylphenidate effects on children with attention deficit hyperactivity disorder: Self-report of symptoms, side-effects, and self-esteem. Journal of Attention Disorders, 1, 3–15.CrossRefGoogle Scholar
  11. DuPaul, G. J., & Carlson, J. S. (2005). Child psychopharmacology: How school psychologists can contribute to effective outcomes. School Psychology Quarterly, 20, 206–221.CrossRefGoogle Scholar
  12. DuPaul, G. J., & Stoner, G. (2014). ADHD in the schools: Assessment and intervention strategies. New York: Guilford Press.Google Scholar
  13. Epstein, J. N., Kelleher, K. J., Baum, R., Brinkman, W. B., Peugh, J., Gardner, W., … Langberg, J. (2014). Variability in ADHD care in community-based pediatrics. Pediatrics, 134, 1136–1143.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Fabiano, G. A., Pelham, W. E., Jr., Gnagy, E. M., Burrows-MacLean, L., Coles, E. K., Chacko, A., et al. (2007). The single and combined effects of multiple intensities of behavior modification and methylphenidate for children with attention deficit hyperactivity disorder. School Psychology Review, 36, 195–216.Google Scholar
  15. Gadow, K. D. (1993). A school-based medication evaluation program. In J. L. Matson (Ed.), Handbook of hyperactivity in children (pp. 186–219).Google Scholar
  16. Gureasko-Moore, D. P., DuPaul, G. J., & Power, T. J. (2005). Stimulant treatment for attention-deficit/hyperactivity disorder: Medication monitoring practices of school psychologists. School Psychology Review, 34, 232–245.Google Scholar
  17. Haile-Mariam, A., Bradley-Johnson, S., & Johnson, C. M. (2002). Pediatricians’ preferences for ADHD information from schools. School Psychology Review, 31, 94–105.Google Scholar
  18. Harvey, R. C., James, A. C., & Shields, G. E. (2016). A systematic review and network meta-analysis to assess the relative efficacy of antipsychotics for the treatment of positive and negative symptoms in early-onset schizophrenia. CNS Drugs, 30, 27–39.PubMedCrossRefGoogle Scholar
  19. Hogue, A., Lichvar, E., & Bobek, M. (2016). Pilot evaluation of the medication integration protocol for adolescents with ADHD in behavioral care: Treatment fidelity and medication uptake. Journal of Emotional and Behavioral Disorders, 24, 223–234.CrossRefGoogle Scholar
  20. Howie, L. D., Pastor, P. N., & Lukacs, S. (2014). Use of medication prescribed for emotional or behavioral difficulties among children aged 6–17 years in the United States, 2011–2012. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.Google Scholar
  21. Hyman, I. A., Wojtowicz, A., Lee, K. D., Haffner, M. E., Fiorello, C. A., Storlazzi, J. J., & Rosenfeld, J. (1998). School-based methylphenidate placebo protocols: Methodological and practical issues. Journal of Learning Disabilities, 31, 581–594.Google Scholar
  22. Jonas, B. S., Gu, Q., & Albertorio-Diaz, J. R. (2013). Psychotropic medication use among adolescents: United States, 2005–2010. NCHS Data Brief, 135, 1–8.Google Scholar
  23. Jensen, P. S., Hinshaw, S. P., Swanson, J. M., Greenhill, L. L., Conners, C. K., Arnold, L. E., … March, J. S. (2001). Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental & Behavioral Pediatrics, 22, 60–73.CrossRefGoogle Scholar
  24. Kieling, C., Baker-Henningham, H., Belfer, M., Conti, G., Ertem, I., Omigbodun, O., … Rahman, A. (2011). Child and adolescent mental health worldwide: Evidence for action. The Lancet, 378, 1515–1525.CrossRefGoogle Scholar
  25. Northup, J., & Gulley, V. (2001). Some contributions of functional analysis to the assessment of behaviors associated with attention deficit hyperactivity disorder and the effects of stimulant medication. School Psychology Review, 30, 227–238.Google Scholar
  26. Northup, J., Gulley, V., Edwards, S., & Fountain, L. (2001). The effects of methylphenidate in the classroom: What dosage, for which children, for what problems? School Psychology Quarterly, 16, 303–323.CrossRefGoogle Scholar
  27. Olfson, M., Druss, B. G., & Marcus, S. C. (2015). Trends in mental health care among children and adolescents. New England Journal of Medicine, 372, 2029–2038.PubMedCrossRefGoogle Scholar
  28. Patel, A., Medhekar, R., Ochoa-Perez, M., Aparasu, R. R., Chan, W., Sherer, J. T., … Chen, H. (2017). Care provision and prescribing practices of physicians treating children and adolescents with ADHD. Psychiatric Services. Advance online publication. Scholar
  29. Pelham, W. E. (1993). Pharmacotherapy for children with attention-deficit hyperactivity disorder. School Psychology Review, 22, 199–227.Google Scholar
  30. Pelham, W. E., Bender, M. E., Caddell, J., Booth, S., & Moorer, S. H. (1985). Methylphenidate and children with attention deficit disorder: Dose effects on classroom academic and social behavior. Archives of General Psychiatry, 42, 948–952.PubMedCrossRefGoogle Scholar
  31. Power, T. J., & Bradley-Klug, K. (2013). Pediatric school psychology: Conceptualization, applications, and strategies for leadership development. New York: Routledge.Google Scholar
  32. Power, T. J., DuPaul, G. J., Shapiro, E. S., & Parrish, J. M. (1995). Pediatric school psychology: The emergence of a subspecialty. School Psychology Review, 24, 244–257.Google Scholar
  33. Power, T. J., Shapiro, E. S., & DuPaul, G. J. (2003). Preparing psychologists to link systems of care in managing and preventing children’s health problems. Journal of Pediatric Psychology, 28, 147–156.PubMedCrossRefGoogle Scholar
  34. Rapport, M. D., DuPaul, G. J., & Kelly, K. L. (1989). Attention-deficit hyperactivity disorder and methylphenidate: The relationship between gross body weight and drug response in children. Psychopharmacology Bulletin, 25, 285–290.PubMedGoogle Scholar
  35. Rapport, M. D., & Moffitt, C. (2002). Attention deficit/hyperactivity disorder and methylphenidate: A review of height/weight, cardiovascular, and somatic complaint side effects. Clinical Psychology Review, 22, 1107–1131.PubMedCrossRefGoogle Scholar
  36. Shahidullah, J. D., & Carlson, J. S. (2014). Survey of nationally certified school psychologists’ roles and training in psychopharmacology. Psychology in the Schools, 51, 705–721.CrossRefGoogle Scholar
  37. Stein, M. A., Sarampote, C. S., Waldman, I. D., Robb, A. S., Conlon, C., Pearl, P. L., … Newcorn, J. H. (2003). A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics, 112, e404–e404.PubMedCrossRefGoogle Scholar
  38. Stoner, G., Carey, S. P., Ikeda, M. J., & Shinn, M. R. (1994). The utility of curriculum-based measurement for evaluating the effects of methylphenidate on academic performance. Journal of Applied Behavior Analysis, 27, 101–113.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Sultan, R. S., & Olfson, M. (2016). National rates of psychotropic medication use in pediatric populations. Journal of the American Academy of Child and Adolescent Psychiatry, 55, S166.CrossRefGoogle Scholar
  40. Vitiello, B., Severe, J. B., Greenhill, L. L., Arnold, L. E., Abikoff, H. B., Bukstein, O. G., … March, J. S. (2001). Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 188–196.CrossRefGoogle Scholar
  41. Volpe, R. J., & Briesch, A. M. (2012). Generalizability and dependability of single-item and multiple-item direct behavior rating scales for engagement and disruptive behavior. School Psychology Review, 41, 246–261.Google Scholar
  42. Volpe, R. J., & Briesch, A. M. (2015). Multi-item direct behavior ratings: Dependability of two levels of assessment specificity. School Psychology Quarterly, 30, 431–442.PubMedCrossRefGoogle Scholar
  43. Volpe, R. J., & Fabiano, G. A. (2013). Daily behavior report cards: An evidence-based system of assessment and intervention. New York: Guilford Press.Google Scholar
  44. Volpe, R. J., & Gadow, K. D. (2010). Creating abbreviated rating scales to monitor classroom inattention-overactivity, aggression, and peer conflict: Reliability, validity, and treatment sensitivity. School Psychology Review, 39, 350–363.Google Scholar
  45. Volpe, R. J., Heick, P. F., & Guerasko-Moore, D. (2005). An agile behavioral model for monitoring the effects of stimulant medication in school settings. Psychology in the Schools, 42, 509–523.CrossRefGoogle Scholar
  46. Walkup, J. T. (2017). Antidepressant efficacy for depression in children and adolescents: Industry-and NIMH-funded studies. American Journal of Psychiatry, 174, 430–437.PubMedCrossRefGoogle Scholar
  47. Zuvekas, S. H., & Vitiello, B. (2012). Stimulant medication use in children: A 12-year perspective. American Journal of Psychiatry, 169, 160–166.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Robert J. Volpe
    • 1
    Email author
  • Brian Daniels
    • 2
  • Christina Sakai
    • 3
  1. 1.Northeastern UniversityBostonUSA
  2. 2.University of Massachusetts, BostonBostonUSA
  3. 3.Floating Hospital for Children at Tufts Medical CenterBostonUSA

Personalised recommendations